CLZR:a potential 10 bagger? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bald Eagle who wrote (13)	1/7/1997 5:12:00 PM
From: Bob Davis	of 315

Newly introduced dermatological laser products are fueling renewed financial growth at Candela Corporation (NASDAQ:CLZR). In its most recent quarter, CLZR reported a 485% increase in net income, resulting from a 28% revenue increase and improved margins on new products. This came on the heels of a 181% increase in net income in its most recent fiscal year. This growth is expected to continue for the next several years. The recent increased acceptance of cryogenic prostate surgery is expected to increase sales for Candela's already widely accepted cryogenic surgical tools. And additional new laser surgical products will be introduced later this year. The Napeague Letter has just published an in-depth analysis of CLZR. If you would like a copy of this Analysis e-mailed to you, please E-mail a request to rmdavis1@ix.netcom.com. This subscription is absolutely free - no one will try to sell you anything and your e-mail address will not be used for any other purposes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next